ProfileGDS5822 / ILMN_2615232
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 82% 82% 75% 82% 81% 82% 87% 81% 78% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1180.382
GSM1276600PDAC Late Ablation Control 2193.482
GSM1276601PDAC Late Ablation Control 3121.875
GSM1276602PDAC Late Ablation 1173.882
GSM1276603PDAC Late Ablation 217681
GSM1276604PDAC Late Ablation 3200.582
GSM1303940PDAC Late Ablation_anti-CTLA4 1324.687
GSM1303941PDAC Late Ablation_anti-CTLA4 2199.981
GSM1303942PDAC Late Ablation_anti-CTLA4 3143.978